Core Viewpoint - Zhejiang Securities has successfully completed the repayment of its sixth short-term financing bond for 2025, indicating the company's financial stability and adherence to its debt obligations [1]. Group 1: Stock Performance - As of October 16, 2025, Zhejiang Securities' stock closed at 11.65 yuan, down 0.34% from the previous trading day [1]. - The stock opened at 11.69 yuan, reached a high of 11.72 yuan, and a low of 11.60 yuan, with a trading volume of 4.66 billion yuan and a turnover rate of 0.87% [1]. Group 2: Financing Bond Details - The sixth short-term financing bond for 2025 was issued on July 7, 2025, with a total issuance size of 2 billion yuan and a coupon rate of 1.59% [1]. - The bond had a maturity of 99 days, with the repayment date set for October 14, 2025, and the total principal and interest paid amounted to 2,008,625,205.48 yuan by the repayment date [1].

Core Viewpoint - YTO Express experienced a decline of 5.12% on October 16, with a stock price of 16.87 yuan per share and a total market capitalization of 577.38 billion yuan [1] Company Overview - YTO Express was established on December 22, 1992, and went public on June 8, 2000. The company is based in Qingpu District, Shanghai, and primarily engages in comprehensive express logistics services [1] - The revenue composition of YTO Express includes: domestic time-sensitive products (89.93%), freight forwarding services (2.91%), air transportation (2.47%), other services (1.75%), supplementary services (1.66%), international express and parcel services (0.83%), and value-added services (0.44%) [1] Fund Holdings - According to data, one fund under Zheshang Securities Asset Management holds a significant position in YTO Express. The Zheshang Huijin Quantitative Selected Stock A (011824) held 72,500 shares in the second quarter, accounting for 0.74% of the fund's net value, making it the sixth-largest holding [2] - The estimated floating loss for the fund today is approximately 66,000 yuan [2] - The Zheshang Huijin Quantitative Selected Stock A (011824) was established on July 1, 2021, with a current scale of 63.808 million yuan. Year-to-date returns are 29.32%, ranking 1753 out of 4218 in its category; the one-year return is 39.78%, ranking 1330 out of 3864; and since inception, the return is 18.94% [2]

Core Viewpoint - Zhejiang Securities maintains a "Buy" rating for Smoore International, projecting significant revenue and profit growth from 2025 to 2027 [1] Financial Projections - Expected revenue for Smoore International: CNY 14.175 billion in 2025, CNY 16.689 billion in 2026, and CNY 19.495 billion in 2027, representing year-on-year growth of +20.14%, +17.73%, and +16.81% respectively [1] - Projected net profit attributable to shareholders: CNY 1.08 billion in 2025, CNY 1.934 billion in 2026, and CNY 2.652 billion in 2027, with year-on-year growth of +17.15%, +79.13%, and +37.10% respectively [1] Market Dynamics - British American Tobacco is increasing resources and marketing efforts for Glo Hilo, with positive sales feedback in Japan and early deployment in several European countries, indicating potential for future growth [1] - The vaping market is expected to recover due to regulatory pressures on illicit tobacco, which bodes well for core supplier Smoore International [1]

Core Viewpoint - Zheshang Securities maintains a "Buy" rating for Smoore International (06969), projecting significant revenue and profit growth from 2025 to 2027 [1] Financial Projections - Expected revenue for Smoore International: - 2025: 14.175 billion - 2026: 16.689 billion - 2027: 19.495 billion - Year-on-year growth: +20.14%, +17.73%, +16.81% [1] - Expected net profit attributable to shareholders: - 2025: 1.08 billion - 2026: 1.934 billion - 2027: 2.652 billion - Year-on-year growth: +17.15%, +79.13%, +37.10% [1] Market Dynamics - British American Tobacco is increasing resources and marketing efforts for Glo Hilo, with positive sales feedback in Japan and early deployment in some European countries [1] - The regulatory crackdown on illegal vaping products is expected to lead to a recovery in the vaping market, which bodes well for core supplier Smoore International [1]

Group 1 - The brokerage sector is experiencing a narrow consolidation with mixed stock performance, as some stocks like Dongxing Securities and Xinda Securities have risen over 2% [1] - Dongwu Securities has announced a projected net profit of 2.748 billion to 3.023 billion yuan for the first three quarters, representing a year-on-year growth of 50% to 65% [3] - The A-share market has shown strong performance with significant growth in new account openings and trading volume, leading to predictions of rapid earnings growth for brokerages in Q3 [3] Group 2 - The brokerage ETF (512000) has seen a capital inflow of 1.643 billion yuan over the past five days, indicating strong investor interest [4] - The latest size of the brokerage ETF has reached 37.493 billion yuan, with an average daily trading volume exceeding 1 billion yuan, making it one of the largest and most liquid ETFs in the A-share market [6] - The ETF tracks the CSI All Share Securities Companies Index, encompassing 49 listed brokerage stocks, with nearly 60% of its holdings concentrated in the top ten leading brokerages [6]

Core Viewpoint - The strategic partnership between Huazhong Holdings and Moli Technology focuses on leveraging AI to enhance factory intelligence, develop embodied robots, create dexterous hands, and innovate lightweight materials, driving industrial upgrades through technological innovation [1][3]. Group 1: Collaboration Focus Areas - The collaboration will emphasize four main areas: smart factory upgrades, embodied robot applications, dexterous hand development, and lightweight material innovation [1]. - In smart factory upgrades, the use of super industrial control machines will facilitate data collection and activation across multiple Huazhong factories, enhancing production efficiency and product quality through intelligent monitoring and predictive maintenance [1]. - Moli Technology plans to integrate its embodied robot technology into Huazhong's core production lines, aiming to overcome traditional automation limitations and improve production line flexibility and adaptability [1]. - The development of dexterous hands will combine Huazhong's application scenarios and manufacturing capabilities with Moli's algorithms to enhance operational precision and intelligence in complex environments [1]. - Huazhong will leverage its expertise in lightweight materials to empower the next generation of robots, improving agility, endurance, and safety in human-robot collaboration [1]. Group 2: Company Backgrounds - Huazhong Holdings is a manufacturer of automotive components, specializing in interior and exterior parts, and is a key supplier to major automotive manufacturers such as FAW-Volkswagen and Volvo [2]. - The automotive parts industry is increasingly investing in robotics to create new growth avenues, particularly in Zhejiang, which has over 100 humanoid robot-related companies, including more than 40 listed on the A-share market [2]. - Moli Technology, established in 2021, focuses on AI-driven robotics, developing various robots for tasks such as inspection, ironing, polishing, and assembly [2]. Group 3: Strategic Goals - The partnership aims to introduce AI technology into manufacturing to address challenges in automotive interior processes, improving quality and reducing costs through AI vision, embodied intelligence, and dexterous hands [3]. - The collaboration is seen as a stepping stone to further explore intelligent manufacturing, new energy, and lightweight materials, with the goal of transforming smart manufacturing from experimental stages into a driving force for high-quality economic development in China [3].

浙商证券（601878）发布研报称，据中国工程机械工业协会，2025年9月销售各类挖掘机19858台，同比 增长25.4%。其中国内销量9249台，同比增长21.5%;出口量10609台，同比增长29%。考虑到工程机械海 外市占率提升，国内更新周期逐步启动，以及2024年下半年业绩基数较低等因素影响，预计工程机械龙 头三季报业绩整体有望实现提速。该行建议持续聚焦行业龙头，推荐三一重工(600031.SH)、徐工机械 （000425）(000425.SZ)等。 考虑到我国工程机械主机厂海外市占率提升，"一带一路"区域城镇化与工业化推进带来的基建和地产需 求增长等因素影响，我国工程机械出口正增长趋势有望延续。国内周期筑底上行主要受益于农林、市政 需求驱动小微挖需求增长，我国主机厂在矿山机械领域持续突破及水利需求带来的大挖及超大挖需求， 以及国内更新需求逐步启动等因素。 浙商证券主要观点如下： 9月挖掘机总销量同比增长25%，其中内销同比增长22%，外销同比增长29% 9月挖掘机总销量19858台，同比增长25%，其中国内销量9249台，同比增长22%;出口量10609台，同比 增长29%。9月总体及内外销同比增速 ...

Core Insights - Inke Medical experienced a 5.05% increase in stock price, reaching 44.97 yuan per share, with a trading volume of 818 million yuan and a turnover rate of 4.08%, resulting in a total market capitalization of 29.446 billion yuan [1] Company Overview - Inke Medical Technology Co., Ltd. is located in Zibo City, Shandong Province, and was established on July 20, 2009, with its listing date on July 21, 2017 [1] - The company's main business segments include personal protection (91.47% of revenue), rehabilitation care (4.75%), and other products (3.77%) [1] Fund Holdings - Zhejiang Merchants Securities Asset Management has a fund that heavily invests in Inke Medical, specifically the Zhejiang Merchants Huijin Quantitative Selected Stock A (011824), which held 40,200 shares, accounting for 0.75% of the fund's net value, making it the second-largest holding [2] - The fund has generated a floating profit of approximately 86,800 yuan as of the report date [2] Fund Performance - The Zhejiang Merchants Huijin Quantitative Selected Stock A fund was established on July 1, 2021, with a current size of 63.808 million yuan [2] - Year-to-date, the fund has achieved a return of 29.32%, ranking 1753 out of 4218 in its category, while its one-year return stands at 39.78%, ranking 1330 out of 3864 [2]

10月16日，普冉股份涨5.09%，截至发稿，报115.28元/股，成交7.62亿元，换手率4.58%，总市值170.67 亿元。 资料显示，普冉半导体(上海)股份有限公司位于上海市浦东新区张江镇银冬路20弄8号楼，成立日期 2016年1月4日，上市日期2021年8月23日，公司主营业务涉及集成电路产品的研发设计和销售。主营业 务收入构成为：芯片收入100.00%。 截至发稿，陈顾君累计任职时间5年271天，现任基金资产总规模2.04亿元，任职期间最佳基金回报 38.6%， 任职期间最差基金回报-7.57%。 风险提示：市场有风险，投资需谨慎。本文为AI大模型自动发布，任何在本文出现的信息（包括但不 限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成个人投资建 议。 责任编辑：小浪快报 数据显示，浙商证券资管旗下1只基金重仓普冉股份。浙商汇金新兴消费（009527）二季度持有股数1万 股，占基金净值比例为2.78%，位居第八大重仓股。根据测算，今日浮盈赚取约5.58万元。 浙商汇金新兴消费（009527）成立日期2020年5月29日，最新规模2273.84万。今年以来收益19.42 ...

Core Viewpoint - The stock of Beijing Hotgen Biotech Co., Ltd. increased by 5.13% on October 16, reaching a price of 179.55 CNY per share, with a trading volume of 320 million CNY and a turnover rate of 1.95%, resulting in a total market capitalization of 16.646 billion CNY [1] Company Overview - Beijing Hotgen Biotech Co., Ltd. was established on June 23, 2005, and went public on September 30, 2019. The company is located in the Daxing Biomedical Industry Base of Zhongguancun Science Park, Beijing [1] - The main business activities include the research, development, production, and sales of in vitro diagnostic reagents and instruments. The revenue composition is as follows: testing reagents 70.87%, testing instruments 19.79%, others 8.17%, and biological raw materials 1.17% [1] Fund Holdings - According to data, one fund under Zheshang Securities Asset Management has a significant holding in Hotgen Biotech. The Zheshang Huijin Quantitative Selected Mixed Fund (006449) held 36,600 shares in the second quarter, accounting for 4.96% of the fund's net value, making it the fourth-largest holding [2] - The fund has a current scale of 104 million CNY and has achieved a return of 55.66% year-to-date, ranking 536 out of 8161 in its category. Over the past year, the return was 49.56%, ranking 1203 out of 8021, and since inception, the return is 51.94% [2] Fund Manager Information - The fund manager of Zheshang Huijin Quantitative Selected Mixed Fund (006449) is Pang Yaqing, who has been in the position for 1 year and 262 days. The total asset size of the fund is 104 million CNY, with the best return during the tenure being 60.13% and the worst return being -11.71% [3]